It has also been demonstrated that LIMD2 levels correlated with the metastatic process in PTCs and invasiveness and poor prognosis in patients melanoma, bladder, and non-small cell lung cancer [6,7,8,18,19]. This evidence concerns the gene LIMD2 and melanoma.